Download PDF

Other users also viewed these articles

The Future of Bronchodilators in COPD and Asthma Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
10.1016/j.arbres.2021.06.005
What's New in the 2022 Consensus for Severe Asthma in Adults Francisco Javier Alvarez-Gutiérrez, Marina Blanco-Aparicio, Francisco Casas-Maldonado, Vicente Plaza, Francisco Javier González-Barcala, José Ángel Carretero-Gracia, Manuel Castilla-Martínez, Carolina Cisneros, David Diaz-Pérez, Christian Domingo-Ribas, Eva Martínez-Moragon, Xavier Muñoz, Alicia Padilla-Galo, Miguel Perpiña-Tordera, Gregorio Soto-Campos
10.1016/j.arbres.2022.09.012
Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD Kun-Ta Chou, Kang-Cheng Su, Yi-Han Hsiao, Shiang-Fen Huang, Hsin-Kuo Ko, Ching-Min Tseng, Vincent Yi-Fong Su, Diahn-Warng Perng
10.1016/j.arbres.2017.01.014